ADMA BIOLOGICS, INC. Inventory, Work in Process, Gross
ADMA BIOLOGICS, INC. (ADMA) had Inventory, Work in Process, Gross of $76.44 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-08-05
- 2026-06-30: Inventory, Work in Process, Gross $76.44M.
- 2026-03-31: Inventory, Work in Process, Gross $67.53M.
- 2025-12-31: Inventory, Work in Process, Gross $57.80M.
- 2025-09-30: Inventory, Work in Process, Gross $44.48M.
| Period end | Inventory, Work in Process, Gross | Inventory, Work in Process, Gross as first filed |
|---|---|---|
| 2026-06-30 | $76.44M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $67.53M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $57.80M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $44.48M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $43.17M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $49.78M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $61.64M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $53.48M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $55.07M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $49.28M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $49.62M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $58.28M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $59.44M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $62.09M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $56.17M 10-K · filed 2024-02-28 | $56.17M 10-K · filed 2023-03-23 |
| 2022-09-30 | $47.52M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $51.14M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $45.14M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $58.97M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $57.26M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $49.16M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $34.56M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $30.29M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $28.44M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $22.07M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $17.14M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $14.46M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $13.96M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $4.67M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $870.26K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-13 | |
| 2018-09-30 | $1.44M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.11M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $1.27M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $1.27M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $801.07K 10-Q · filed 2017-11-03 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |